BackPoseida Therapeutics Overview

Poseida Therapeutics Profit Margin

Profitability ratio analysis for PSTX.

Quarterly Profit Margin

28.20%
↑ 108.30% YoY

As of Sep 2024

Annual Profit Margin (TTM)

-39.37%
↑ 85.24% YoY

Trailing 12 months ending Sep 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin